Common neural signatures of psychedelics: frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition
This academic book chapter (2018) uses the new concepts of connectome harmonics and connectome-harmonic decomposition to describe the brain activity associated with the psychedelic state. A heightened state of criticality on both LSD and psilocybin is observed.
Authors
- Robin Carhart-Harris
- Morten Kringelbach
- Gustavo Deco
Published
Abstract
The search for the universal laws of human brain function is still on-going but progress is being made. Here we describe the novel concepts of connectome harmonics and connectome-harmonic decomposition, which can be used to characterize the brain activity associated with any mental state. We use this new frequency-specific language to describe the brain activity elicited by psilocybin and LSD and find remarkably similar effects in terms of increases in total energy and power, as well as frequency-specific energy changes and repertoire expansion. In addition, we find enhanced signatures of criticality suggesting that the brain dynamics tune toward criticality in both psychedelic elicited states. Overall, our findings provide new evidence for the remarkable ability of psychedelics to change the spatiotemporal dynamics of the human brain.
Research Summary of 'Common neural signatures of psychedelics: frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition'
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typeindividual
- Journal
- Compounds
- Topic
- Authors
- APA Citation
Atasoy, S., Vohryzek, J., Deco, G., Carhart-Harris, R. L., & Kringelbach, M. L. (2018). Common neural signatures of psychedelics: frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition. Progress in Brain Research, 97-120. https://doi.org/10.1016/bs.pbr.2018.08.009
Cited By (13)
Papers in Blossom that reference this study
Mäki-Marttunen, V. · Communications Biology (2026)
Vohryzek, J., Luppi, A. I., Atasoy, S. et al. · Neuropsychopharmacology (2025)
Socoró-Garrigosa, M., Sanz Perl, Y., Kringelbach, M. L. et al. · Annals of the New York Academy of Sciences (2025)
Lewis, E. C., Jaeger, A., Girn, M. et al. · Journal of Psychopharmacology (2024)
Erritzoe, D., Timmermann, C., Godfrey, K. et al. · Nature Mental Health (2024)
Vohryzek, J., Cabral, J., Timmermann, C. et al. · National Science Review (2023)
Luppi, A. I., Vohryzek, J., Kringelbach, M. L. et al. · Communications Biology (2023)
Singleton, S. P., Luppi, A. I., Carhart-Harris, R. L. et al. · Nature Communications (2022)
Cruzat, J., Perl, Y. S., Escrichs, A. et al. · Network Neuroscience (2022)
Luppi, A. I., Carhart-Harris, R. L., Roseman, L. et al. · NeuroImage (2021)
Show all 13 papersShow fewer
Kadriu, B., Greenwald, M., Ba et al. · International Journal of Neuropsychopharmacology (2020)
Girn, M., Mills, C., Roseman, L. et al. · NeuroImage (2020)
Lord, L. D., Expert, P., Atasoy, S. et al. · NeuroImage (2019)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.